Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Change in Receivables (2018 - 2025)

Historic Change in Receivables for X4 Pharmaceuticals (XFOR) over the last 4 years, with Q3 2025 value amounting to -$254000.0.

  • X4 Pharmaceuticals' Change in Receivables changed N/A to -$254000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $891000.0, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • Per X4 Pharmaceuticals' latest filing, its Change in Receivables stood at -$254000.0 for Q3 2025.
  • X4 Pharmaceuticals' Change in Receivables' 5-year high stood at $1.1 million during Q4 2024, with a 5-year trough of -$561000.0 in Q1 2025.